Boditech Med Inc. (KOSDAQ:206640)
South Korea
· Delayed Price · Currency is KRW 11,340
-760 (-6.28%)
At close: Mar 9, 2026
Boditech Med Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 247,022 | 368,764 | 450,360 | 225,170 | 382,205 | 545,546 | Upgrade
|
| Market Cap Growth | -29.93% | -18.12% | 100.01% | -41.09% | -29.94% | 146.19% | Upgrade
|
| Enterprise Value | 243,108 | 321,766 | 398,068 | 182,995 | 329,122 | 520,102 | Upgrade
|
| Last Close Price | 11340.00 | 16622.29 | 20019.69 | 10009.85 | 16167.45 | 22524.33 | Upgrade
|
| PE Ratio | 9.07 | 13.53 | 17.36 | 9.32 | 8.62 | 11.99 | Upgrade
|
| Forward PE | - | 23.45 | 23.45 | 23.45 | 23.45 | 23.45 | Upgrade
|
| PS Ratio | 1.63 | 2.67 | 3.36 | 1.91 | 2.42 | 3.79 | Upgrade
|
| PB Ratio | 1.04 | 1.65 | 2.28 | 1.29 | 2.37 | 4.33 | Upgrade
|
| P/TBV Ratio | 1.13 | 1.79 | 2.47 | 1.42 | 2.61 | 4.73 | Upgrade
|
| P/FCF Ratio | - | 27.41 | 15.17 | 28.84 | 12.06 | 13.45 | Upgrade
|
| P/OCF Ratio | 11.90 | 14.82 | 13.13 | 9.76 | 7.66 | 12.22 | Upgrade
|
| EV/Sales Ratio | 1.60 | 2.33 | 2.97 | 1.55 | 2.09 | 3.61 | Upgrade
|
| EV/EBITDA Ratio | 6.48 | 9.31 | 10.91 | 5.69 | 5.68 | 7.28 | Upgrade
|
| EV/EBIT Ratio | 8.73 | 12.31 | 14.09 | 7.42 | 6.34 | 7.88 | Upgrade
|
| EV/FCF Ratio | -21.04 | 23.92 | 13.41 | 23.44 | 10.38 | 12.82 | Upgrade
|
| Debt / Equity Ratio | 0.07 | 0.05 | 0.05 | 0.05 | 0.04 | 0.10 | Upgrade
|
| Debt / EBITDA Ratio | 0.49 | 0.32 | 0.29 | 0.28 | 0.12 | 0.17 | Upgrade
|
| Debt / FCF Ratio | - | 0.82 | 0.36 | 1.14 | 0.22 | 0.29 | Upgrade
|
| Net Debt / Equity Ratio | -0.07 | -0.23 | -0.33 | -0.29 | -0.38 | -0.37 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.49 | -1.46 | -1.80 | -1.60 | -1.06 | -0.66 | Upgrade
|
| Net Debt / FCF Ratio | 1.51 | -3.76 | -2.21 | -6.60 | -1.94 | -1.16 | Upgrade
|
| Asset Turnover | 0.58 | 0.57 | 0.63 | 0.61 | 0.89 | 1.09 | Upgrade
|
| Inventory Turnover | 1.69 | 1.62 | 1.72 | 1.48 | 2.07 | 2.41 | Upgrade
|
| Quick Ratio | 3.21 | 3.38 | 3.83 | 5.18 | 3.51 | 2.84 | Upgrade
|
| Current Ratio | 5.05 | 4.96 | 5.09 | 7.28 | 4.84 | 3.65 | Upgrade
|
| Return on Equity (ROE) | 11.89% | 12.95% | 14.33% | 15.05% | 32.99% | 47.55% | Upgrade
|
| Return on Assets (ROA) | 6.25% | 6.77% | 8.34% | 7.95% | 18.25% | 31.17% | Upgrade
|
| Return on Invested Capital (ROIC) | 10.92% | 14.43% | 18.72% | 20.76% | 49.22% | 72.06% | Upgrade
|
| Return on Capital Employed (ROCE) | 10.40% | 11.50% | 14.10% | 13.70% | 31.50% | 50.70% | Upgrade
|
| Earnings Yield | 11.02% | 7.39% | 5.76% | 10.73% | 11.61% | 8.34% | Upgrade
|
| FCF Yield | -4.68% | 3.65% | 6.59% | 3.47% | 8.29% | 7.44% | Upgrade
|
| Dividend Yield | 1.24% | 0.90% | 1.00% | 1.50% | 1.24% | 0.89% | Upgrade
|
| Payout Ratio | 12.00% | 16.12% | 12.70% | 17.68% | 10.39% | 2.52% | Upgrade
|
| Buyback Yield / Dilution | 0.96% | 0.13% | 1.77% | 2.41% | 0.47% | -0.14% | Upgrade
|
| Total Shareholder Return | 2.20% | 1.03% | 2.77% | 3.91% | 1.70% | 0.75% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.